H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 Trial
Kapoor noted the early start of dosing for OKRA-002 to be a significant milestone for the company.
Oruka Therapeutics Inc. (ORKA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 0 | $0 | 0% | |
| 5. | Avidity Partners Management David Witzke And Michael Gregory | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.44 | 88,794 | $1,015,803.36 | 4,148,428 | 2025-02-14 | Filing | |
| $11.63 | 14,950 | $173,868.50 | 4,059,634 | 2025-02-13 | Filing | |
| $11.86 | 8,971 | $106,396.06 | 4,044,684 | 2025-02-12 | Filing | |
| $10.95 | 9,593 | $105,043.35 | 4,035,713 | 2025-02-11 | Filing | |
| $10.90 | 574 | $6,256.60 | 4,026,120 | 2025-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.50 | 482 | $241.72 | 13,153 | 2018-04-03 | Filing | |
| $0.50 | 1,114 | $556.33 | 0 | 2018-04-02 | Filing | |
| $0.72 | 410 | $294.38 | 13,635 | 2018-02-28 | Filing | |
| $0.53 | 161 | $85.33 | 1,114 | 2018-02-27 | Filing | |
| $0.53 | 41,331 | $21,905.43 | 0 | 2018-02-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Billionaire Hedge Funds
